Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 27, 2023. (Total: 217315Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Disease Progression and meta-analysis and EGFR[original query]
Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
PloS one 2013 8 (11): e79000.
OuYang Pu-Yun, Su Zhen, Mao Yan-Ping, Deng Wuguo, Xie Fang-Y
Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.
Archives of medical science : AMS 2014 Feb 10 (1): 1-9.
Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Journal of the National Cancer Institute 2017 Jun 109 (6): .
Lee Chee Khoon, Davies Lucy, Wu Yi-Long, Mitsudomi Tetsuya, Inoue Akira, Rosell Rafael, Zhou Caicun, Nakagawa Kazuhiko, Thongprasert Sumitra, Fukuoka Masahiro, Lord Sally, Marschner Ian, Tu Yu-Kang, Gralla Richard J, Gebski Val, Mok Tony, Yang James Chih-Hs
A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC.
Mathematical biosciences and engineering : MBE 2019 9 16 (5): 5687-5696.
Li Yong Xing, Yang Jian Ye, Xu Yu Fen, Zhang Ming, Zhang Xiao Ping, Chen Wen Yu, Lv Xiao Do
The impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis.
Expert review of anticancer therapy 2019 May .
Qin Qin, Peng Bing, Li Baoshe
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
Cancer medicine 2019 Dec .
Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly
Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis.
Experimental oncology 2021 09 43 (3): 252-256.
Vlachou M S, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, Pentheroudakis
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
BioMed research international 2021 8850256.
Ma Jie-Tao, Guo Yi-Jia, Song Jun, Sun Li, Zhang Shu-Ling, Huang Le-Tian, Jing Wei, Zhao Jian-Zhu, Han Cheng-
Should We Perform Repeated Re-Biopsy for the Detection of T790M Mutation?
Cancer research and treatment 2023 4 .
Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop E
TOP